Can-Fite BioPharma (CANF) has released an update.
Can-Fite BioPharma Ltd. announced that its Annual General Meeting, scheduled for June 26, 2024, was postponed due to lack of quorum and has been rescheduled for July 3, 2024. The reconvened meeting will take place at the company’s headquarters in Ramat Gan, Israel.
For further insights into CANF stock, check out TipRanks’ Stock Analysis page.
